HIV Regulatory Proteins: Potential Targets for Therapeutic Intervention
- 1 February 1992
- journal article
- review article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 8 (2) , 175-181
- https://doi.org/10.1089/aid.1992.8.175
Abstract
With the incidence of HIV infection on the rise worldwide, it is obvious that new approaches must be taken to halt the spread of disease. Unfortunately, this is no easy task; of all retroviruses studied to date HIV remains the most complex in terms of genomic organization, regulation of gene expression, and replication. However, as the mechanism of action of the unique viral regulatory proteins is deciphered, new windows of opportunity for attacking the virus like cycle are opened. The essential regulatory function served by both Tat and Rev transacting regulatory proteins makes them attractive targets for prophylactic and therapeutic intervention. This review will focus on our current understanding of Tat and Rev function.Keywords
This publication has 81 references indexed in Scilit:
- RNA recognition by Tat-derived peptides: Interaction in the major groove?Cell, 1991
- Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.Genes & Development, 1990
- Secondary Structure is the Major Determinant for Interaction of HIV rev Protein with RNAScience, 1990
- Functional Analysis of CAR, the Target Sequence for the Rev Protein of HIV-1Science, 1989
- Human Chromosome 12 Is Required for Elevated HIV-1 Expression in Human-Hamster Hybrid CellsScience, 1989
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988
- Expression and Characterization of the Trans -Activator of HTLV-III/LAV VirusScience, 1986
- Location of the Trans -Activating Region on the Genome of Human T-Cell Lymphotropic Virus Type IIIScience, 1985
- Trans -Activator Gene of Human T-Lymphotropic Virus Type III (HTLV-III)Science, 1985
- The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeatCell, 1985